Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal Cancer.

Saved in:
Bibliographic Details
Title: Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal Cancer.
Authors: Abiodun AT; Institute of Cardiovascular Science, University College London, United Kingdom; Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom; National Disease Registration Service, NHS England, Wellington Place, Leeds, United Kingdom., Ju C; Institute of Cardiovascular Science, University College London, United Kingdom; National Disease Registration Service, NHS England, Wellington Place, Leeds, United Kingdom; Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom., Welch CA; National Disease Registration Service, NHS England, Wellington Place, Leeds, United Kingdom; Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom., Lai J; National Disease Registration Service, NHS England, Wellington Place, Leeds, United Kingdom., Tyrer F; National Disease Registration Service, NHS England, Wellington Place, Leeds, United Kingdom; Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom., Chambers P; Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom; Cancer Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom; Centre for Medicines Optimization Research and Education, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Paley L; National Disease Registration Service, NHS England, Wellington Place, Leeds, United Kingdom., Vernon S; National Disease Registration Service, NHS England, Wellington Place, Leeds, United Kingdom., Deanfield J; Institute of Cardiovascular Science, University College London, United Kingdom; National Institute of Cardiovascular Outcomes Research, NHS Arden and Greater East Midlands Commissioning Support Unit, Leicester, United Kingdom., de Belder M; National Institute of Cardiovascular Outcomes Research, NHS Arden and Greater East Midlands Commissioning Support Unit, Leicester, United Kingdom., Rutherford MJ; Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom., Lambert PC; Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden., Slater S; Barts Cancer Centre, Barts Health NHS Trust, London, United Kingdom., Shiu KK; Cancer Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom; Cancer Institute, University College London, London, United Kingdom., Wei L; Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom; Centre for Medicines Optimization Research and Education, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Peake MD; Department of Respiratory Medicine, University of Leicester, Glenfield Hospital, Leicester, United Kingdom; Cancer Research UK, London, England., Adlam D; Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Glenfield Hospital, Leicester, United Kingdom., Manisty C; Institute of Cardiovascular Science, University College London, United Kingdom; Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom; National Disease Registration Service, NHS England, Wellington Place, Leeds, United Kingdom. Electronic address: c.manisty@ucl.ac.uk.
Corporate Authors: NICOR Collaborative
Source: JACC. CardioOncology [JACC CardioOncol] 2025 Jun; Vol. 7 (4), pp. 345-356. Date of Electronic Publication: 2025 Apr 08.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101761697 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-0873 (Electronic) Linking ISSN: 26660873 NLM ISO Abbreviation: JACC CardioOncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-0873
DOI:10.1016/j.jaccao.2025.01.019